Targeting the DNA damage response enhances CD70 CAR-T cell therapy for renal carcinoma by activating the cGAS-STING pathway.
J Hematol Oncol. 2021 Sep 23;14(1):152. doi: 10.1186/s13045-021-01168-1.
J Hematol Oncol. 2021.
PMID: 34556152
Free PMC article.